Mirum Pharmaceuticals (MIRM) Insider Trading & Ownership → 1970’s computer coder Issues Shocking AI Warning (From InvestorPlace) (Ad) Free MIRM Stock Alerts $25.81 +0.77 (+3.08%) (As of 02:57 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Mirum Pharmaceuticals (NASDAQ:MIRM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.87%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$4.42 MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$1.21 M Get MIRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Mirum Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MIRM Insider Buying and Selling by Quarter Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Mirum Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/27/2024Eric BjerkholtCFOBuy2,000$24.80$49,600.00 3/25/2024Peter RadovichCOOSell4,303$25.80$111,017.40 3/18/2024Eric BjerkholtCFOBuy2,000$25.80$51,600.00 2/2/2024Jolanda HoweSVPSell735$26.19$19,249.65 1/8/2024Christopher PeetzCEOSell5,209$28.03$146,008.27 1/8/2024Jolanda HoweSVPSell528$28.04$14,805.12 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/8/2024Lara LongpreInsiderSell1,019$28.04$28,572.76 1/8/2024Peter RadovichCOOSell1,408$28.03$39,466.24 12/5/2023Jolanda HoweSVPSell2,500$32.40$81,000.00 9/14/2023Michael G. GreyDirectorSell14,216$32.00$454,912.00 9/11/2023Eric BjerkholtCFOBuy10,000$29.65$296,500.00 9/11/2023Patrick J HeronDirectorBuy4,687$30.30$142,016.10 8/31/2023Patrick J HeronDirectorBuy147,991$26.25$3,884,763.75 8/25/2023Jolanda HoweSVPSell3,459$26.23$90,729.57 7/3/2023Christopher PeetzCEOSell5,498$25.65$141,023.70 7/3/2023Jolanda HoweSVPSell915$25.65$23,469.75 7/3/2023Lara LongpreInsiderSell1,004$25.65$25,752.60 7/3/2023Peter RadovichCOOSell1,425$25.65$36,551.25 (Data available from 1/1/2013 forward) MIRM Insider Trading Activity - Frequently Asked Questions Who is on Mirum Pharmaceuticals's Insider Roster? The list of insiders at Mirum Pharmaceuticals includes Christopher Peetz, Eric Bjerkholt, Ian Clements, James E Flynn, Jolanda Howe, Lara Longpre, Michael G. Grey, Niall O'donnell, Pamela Vig, Patrick J Heron, and Peter Radovich. Learn more on insiders at MIRM. What percentage of Mirum Pharmaceuticals stock is owned by insiders? 22.87% of Mirum Pharmaceuticals stock is owned by insiders. Learn more on MIRM's insider holdings. Which Mirum Pharmaceuticals insiders have been buying company stock? The following insiders have purchased MIRM shares in the last 24 months: Eric Bjerkholt ($397,700.00), and Patrick J Heron ($4,026,779.85). How much insider buying is happening at Mirum Pharmaceuticals? Insiders have purchased a total of 166,678 MIRM shares in the last 24 months for a total of $4,424,479.85 bought. Which Mirum Pharmaceuticals insiders have been selling company stock? The following insiders have sold MIRM shares in the last 24 months: Christopher Peetz ($287,031.97), James E Flynn ($962,334.78), Jolanda Howe ($229,254.09), Lara Longpre ($54,325.36), Michael G. Grey ($863,936.00), Niall O'donnell ($4,110,015.19), and Peter Radovich ($187,034.89). How much insider selling is happening at Mirum Pharmaceuticals? Insiders have sold a total of 301,535 Mirum Pharmaceuticals shares in the last 24 months for a total of $6,693,932.28 sold. More Insider Trading Tools from MarketBeat Related Companies: Collegium Pharmaceutical Insider Trading Ironwood Pharmaceuticals Insider Trading Pacira BioSciences Insider Trading Gemini Therapeutics Insider Trading Ligand Pharmaceuticals Insider Trading Verona Pharma Insider Trading MannKind Insider Trading AbCellera Biologics Insider Trading Prothena Insider Trading Xencor Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:MIRM) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThings Are Not Normal in America – Here’s What to DoStansberry Research1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mirum Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.